 Chemomab Therapeutics Ltd. NASDAQ:CMMB Q1 2022 Earnings Conference Call May 11, 2022 8:00 AM ET Company Participants Barbara Lindheim - Consulting Vice President Investor Public Relations Dale Pfost - Chairman CEO David Weiner - Interim CMO Don Marvin - CFO, COO EVP Adi Mor - Co-Founder Chief Scientific Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Jeff Jones - Oppenheimer Nathan Weinstein - Aegis Capital Operator Greetings and welcome to the Chemomab First Quarter 2022 Earnings Call. 